Your browser is no longer supported. Please, upgrade your browser.
Settings
THTX [NASD]
Theratechnologies Inc.
Index- P/E- EPS (ttm)- Insider Own1.19% Shs Outstand94.60M Perf Week1.15%
Market Cap333.94M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float86.79M Perf Month-5.87%
Income- PEG- EPS next Q- Inst Own25.48% Short Float0.18% Perf Quarter0.86%
Sales66.39M P/S5.03 EPS this Y- Inst Trans- Short Ratio0.93 Perf Half Y2.92%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year67.30%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.83 - 4.46 Perf YTD41.20%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-20.85% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low92.90% ATR0.16
Employees54 Current Ratio- Sales Q/Q3.60% Oper. Margin- RSI (14)45.04 Volatility2.75% 5.26%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.46 Prev Close3.50
ShortableYes LT Debt/Eq- EarningsOct 13 BMO Payout- Avg Volume168.00K Price3.53
Recom- SMA20-3.57% SMA50-2.02% SMA2003.46% Volume77,844 Change0.86%
Jul-29-21Downgrade Canaccord Genuity Buy → Hold $8 → $3
Oct-13-21 07:00AM  
Oct-06-21 08:30AM  
Sep-29-21 08:30AM  
Sep-22-21 08:08AM  
Sep-16-21 09:02AM  
Aug-13-21 09:08AM  
Aug-04-21 08:00AM  
Jul-27-21 10:17AM  
Jul-23-21 07:30PM  
Jul-15-21 07:00AM  
Jun-30-21 11:28AM  
07:30AM  
Jun-28-21 01:49PM  
Jun-23-21 07:30AM  
Jun-21-21 09:00AM  
Jun-10-21 04:01PM  
May-31-21 08:00AM  
May-20-21 07:30AM  
May-18-21 09:24AM  
May-13-21 11:15AM  
Apr-19-21 01:32AM  
Apr-14-21 07:30AM  
06:15AM  
Apr-12-21 04:30PM  
01:46PM  
Apr-10-21 10:02AM  
Mar-29-21 01:00PM  
Mar-24-21 07:30AM  
Mar-23-21 06:47AM  
Mar-20-21 11:00AM  
Mar-10-21 04:30PM  
Feb-25-21 04:43PM  
07:30AM  
06:30AM  
Feb-11-21 10:21AM  
Feb-04-21 08:24AM  
07:30AM  
Jan-22-21 05:16AM  
Jan-19-21 09:41AM  
Jan-14-21 09:49AM  
Jan-11-21 08:19PM  
07:13PM  
Jan-07-21 07:00AM  
Dec-08-20 07:00AM  
Nov-23-20 04:01PM  
Nov-16-20 10:31AM  
Nov-06-20 01:36PM  
Nov-03-20 04:01PM  
Oct-22-20 04:10PM  
Oct-19-20 07:21AM  
Oct-16-20 07:30AM  
Oct-15-20 04:30PM  
07:00AM  
06:30AM  
Oct-14-20 07:53AM  
Oct-13-20 04:37PM  
Oct-05-20 04:01PM  
Sep-30-20 04:01PM  
Sep-21-20 07:30AM  
Sep-10-20 07:30AM  
02:00AM  
Jul-30-20 07:30AM  
Jul-23-20 04:01PM  
Jul-18-20 10:31AM  
Jul-16-20 12:23PM  
Jul-15-20 10:30PM  
07:30AM  
06:30AM  
Jul-07-20 07:30AM  
Jul-06-20 07:30AM  
Jun-22-20 07:30AM  
May-15-20 07:30AM  
May-12-20 07:30AM  
Apr-27-20 07:30AM  
Apr-16-20 03:23PM  
07:30AM  
Apr-14-20 07:30AM  
06:30AM  
Mar-31-20 07:30AM  
Mar-11-20 12:00PM  
Mar-02-20 08:00AM  
Feb-27-20 08:14AM  
Feb-25-20 07:30AM  
06:30AM  
Feb-18-20 08:00AM  
Feb-04-20 07:30AM  
Dec-19-19 09:06AM  
Dec-13-19 07:30AM  
Oct-17-19 02:42PM  
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.